Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Statement from the founders of Evolution Gaming Group AB (publ)

(Clarification: in the original release, the wording regarding the total number of shares sold could be misinterpreted. Jens von Bahr and Fredrik Österberg have sold 1,798,520 shares in total.) Jens von Bahr and Fredrik Österberg, through JOvB Investment AB and Fros Ventures AB, have sold 1,798,520 shares in Evolution Gaming Group through an accelerated bookbuilding process to Swedish and international institutional investors at a price of SEK 557 per share, corresponding to approximately 5% of all outstanding shares in Evolution Gaming.Dear friends, colleagues and shareholders, As co-

Release of Report for the Third Quarter Ended September 30, 2017

Please note that the report for the third quarter ended September 30, 2017 will be released on the 27th of November, 2017 at 9:00 am CET.An international conference call for investors and analysts will be held on the 4th of December, 2017 at 3:00 pm CET. The dial-in number is +46 8 5052 0110 meeting code: Preem. For further information, please contact:Amelie Wilson                                                            Investor Relations Manager                                          Tel: + 46 (0)10-450 10 21                                                 Email: amelie.

Boliden’s Capital Market Day 2017: Delivering value through operational excellence

Boliden’s Capital Market Day includes presentations of Boliden’s executive management in Stockholm, and a visit to the Kevitsa mine, that was acquired half way through 2016. On both occasions, Boliden will meet representatives from the capital market with the aim of contributing to an increased understanding of how Boliden’s strategy generates long-term value.“Our strategy’s starting point is maintaining stable and efficient operations. Our corporate culture is central to developing productivity and competitiveness. At the same time, our ability to combine huge investments and new

European Directories Group releases January - September 2017 interim results

21 NOVEMBER 2017European Directories Group announces today its January – September 2017 interim results.   The interim report can be found on the website www.europeandirectories.com/investors. For further information, please contact:    Group CFO   Neil Robson  Tel +31 20 408 64 00   E-mail: ir@europeandirectories.com  European Directories Group is an online partner for SMEs offering local search and lead generation with a scalable business model. The European Directories Group operates through three main brands: Fonecta in Finland, Herold in Austria and DTG in the

Södra selects Ledinek’s equipment for CLT facility

Södra has selected Ledinek as supplier of the equipment for the cross-laminated timber (CLT) facility that Södra has decided to build at Värö.In mid-September, Södra decided to invest in a small CLT facility adjacent to Södra’s sawmill at Värö. The facility will have an annual capacity of about 5,000 m³ per shift, and require 3-5 new employees during 2018-19. The plans include a future investment in a larger facility. The contract with Ledinek includes feeding, finger-jointing, saw, sorting, stacking, gluing, pressing and CNC* milling equipment. The facility is being built as a pilot

Seamless Distribution AB (publ) announces the final terms and conditions for the rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, HONG KONG, SWITZERLAND, NEW ZEALAND, OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT INFORMATION AT THE END OF THE PRESS RELEASESeamless Distribution AB (publ) (the “Company” or “Seamless”) (Nasdaq Stockholm: SEAM) announced on October 25, 2017, that the Board of Seamless had resolved

NeuroVive Pharmaceutical AB Interim report January - September 2017

Continued positive trend for NeuroSTAT® Business operationsSignificant events July-September 2017  · NeuroVive received positive feedback from the European Medicines Agency (EMA) regarding the NeuroSTAT development plan. · NeuroVive signed a private placement agreement with Esousa Holdings LLC totalling SEK 4.5 million excluding transaction costs. · NeuroVive hosted a Mitochondria Day at IVA in Stockholm to raise awareness of mitochondrial disorders. Important events after the end of the period  · NeuroVive received a positive opinion from the the European

2017 Q3 report, July-September for Panion Animal Health AB

Period July-September · Net sales: kSEK 0 (0) · Operating profit: kSEK -923 (-43) · Earnings per share: SEK -0,25 (-0,01) · Liquidity at the end of the period: kSEK 1 166 (541) Period January-Sept · Net sales: kSEK 0 (0). · Operating profit: kSEK -3 501 (-43) · Earnings per share: SEK -0,25 (-0,01) · Liquidity at the end of the period: kSEK 1 166 (541) Milestones July-September 2017 · Panion’s business and structure was approved by AktieTorget on the 3.rd of July and the shares could then be listed on the MTF under the name “Panion”. First trading day

Pandox AB (publ) is evaluating the possibilities for a major acquisition

Following speculation in the media Pandox confirms that the company has entered a negotiating phase concerning the possibilities for a major acquisition. The acquisition concerns a hotel portfolio focused on larger cities in Great Britain and the Republic of Ireland. Pandox would like to emphasise that the deal is complex and that current negotiations may not necessarily lead to an agreement, and that it is not certain that the transaction will be successfully concluded.Pandox is a leading hotel property owner in Europe. The company owns 122 hotel properties in eleven countries, including

The website www.diagnode-2.com launched for recruitment of patients for DIAGNODE-2 trial

www.diagnode-2.com is aiming to reach patients aged 12–24 years recently diagnosed with type 1 diabetes and their relatives, to inform about the opportunity to volunteer to participate in the DIAGNODE-2 clinical trial.The website for the European Phase II trial DIAGNODE-2 has been approved by the Ethics Committees in the participating countries Sweden, the Czech Republic and Spain. Information regarding the clinics’ recruitment status will be updated continuously when sites become activated to recruit patients. For further information about DIAGNODE-2 and participating clinics, please visit

​Flowscape merges with Crowdsoft and reinforces the offering

Flowscape reinforces the offering to the market for IT-based office solutions by merging with the progressive company Crowdsoft Technology. The deal is expected to be finalized at Crowdsoft's Annual General Meeting on December 20th. Crowdsoft's C-One product provides businesses, governments and organizations with an intelligent solution for large-scale communications management. The system is primarily used to handle service organizations and security issues. A major customer is the largest hospital in Sweden: Karolinska Sjukhuset. Flowscape has defined a clear vision of positioning

Parans secures external financing of up to SEK 30 million and issues free warrants to its shareholders

Parans Solar Lighting AB (publ) ("Parans") has signed an agreement relating to an investment of up to SEK 30 million. The capital will be used to secure the ongoing launch of the new SP4 system relating to marketing investments and build-up of the production capacity. The transaction is carried out through a private placement of convertible notes (the “Notes”) with warrants attached (the “Warrants”) in several tranches spread over 36 months (each, a “Tranche”). - The agreement will be an important part of our work to secure sufficient funds to continue the launch of the new SP4 system,

Interim report Q3 2017

Continued strong growth with sustained profitabilityThird quarter (July-Sep 2017) · Revenue increased by 26% to MEUR 19.3 (15.3) · B2B Revenue increased by 31% to MEUR 10.1 (7.7) · EBITDA increased by 44% to MEUR 4.2 (2.9) · EBITDA margin increased to 22% (19%) · EBIT increased by 44% to MEUR 3.9 (2.7) · Earnings after tax amounted to MEUR 3.6 (2.3) · Earnings per share, after tax, from continued operations amounted to EUR 0.08 (0.05) · First Time Depositors (FTDs) increased by 40% to 63.9 thousand (45.7) · Revenue increased by 15% to MEUR 52.8 (45.9) · B2B

AcadeMedia announces the final terms of its rights issue

AcadeMedia announced on October 24, 2017 that the Board of Directors had resolved on a rights issue of approximately SEK 400 million with pre-emptive rights for existing shareholders. The rights issue is subject to approval by the annual general meeting, which is held on November 24, 2017. The Board of Directors of AcadeMedia announces today the final terms of the rights issue. NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, HONG KONG, SWITZERLAND, NEW ZEALAND, SINGAPORE OR SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE

Lantmännen in search of tomorrow’s agtech innovations

The future of farming is digital. Agtech, or agricultural technology, is the next theme for the Lantmännen Växthus (Greenhouse) spring 2018 – an accelerator program for agricultural innovations. The program helps entrepreneurs, both within Lantmännen and externally, to develop their ideas into profitable businesses. The spring program is now open for applications.Entrepreneurs with a business idea within agtech will be given the opportunity to develop their ideas in Lantmännen’s Greenhouse during the spring of 2018, a program in partnership with Agroväst – a development company within green

Read original

New study results support use of DiviTum® for evaluation of pancreatic cancer

Uppsala, Sweden, November 21, 2017. In collaboration with University of Heidelberg, Germany, results from a clinical study of pancreatic cancer is published in the Pancreas scientific journal. The results demonstrate that Biovica’s DiviTum assay can provide an accurate prognosis and evaluation of treatment efficacy.The proof of concept study, including 404 patients, provides evidence for using DiviTum as a dynamic biomarker before and during therapy to give important answers regarding prognosis and how effective therapy is. Biovica’s assay was prognostic for overall survival in all patients.

Tieto strengthens its digital offering in the elderly care area – acquires software assets and related rights of VisueCare in Sweden

Tieto today announced that it has acquired the intellectual property rights of Swedish startup company VisueCare. The aim is to strengthen the company´s industry specific software capabilities and widen the offering related to elderly care for municipalities. VisueCare´s cloud-based solution is developed to handle sheltered living for elderly and disabled people, enabling easy access to relevant information, better collaboration between staff and improved quality of care."The Swedish healthcare and welfare market is a prioritized area for us. This transaction gives us the opportunity to

Interim report January - September 2017

July to September · Net sales amounted to MSEK 0 (0) · The operating profit for the period was -4.4 (-1.8) MSEK · Net loss was 4.8 (loss 2.1) MSEK, corresponding to a loss per share of SEK 0.24 (loss 0.16) · Cash flow from operating activities amounted to 15.2 (-2.2) MSEK · Cash and cash equivalents amounted to 72.6 (8.6) MSEK January to September · Net sales amounted to MSEK 0 (0) · The operating profit for the period was 0.9 (loss 3.9) MSEK · Net profit was 2.5 (loss 4.6) MSEK, corresponding to earnings per share of SEK 0.16 (loss 0.35) · Cash flow from

21st Century Oncology chooses Elekta for replacement of radiation therapy devices

Hospitals in seven U.S. states to upgrade to Elekta’s Versa HD linear acceleratorsSTOCKHOLM, November 21, 2017 – Elekta (EKTA-B.ST) announces that 21st Century Oncology, the largest radiation oncology provider in the U.S., will replace several of its existing linear accelerators, as well as treatment planning software and oncology information systems, with advanced cancer treatment solutions from Elekta. The agreement includes Elekta’s Versa HD™  linear accelerators, which combines high definition dynamic radiosurgery and precision radiation therapy treatments

Orkla invests in digital commerce

Orkla has entered into an agreement to purchase the Swedish company Health and Sports Nutrition Group HSNG AB ("HSNG"). HSNG runs the eCommerce portals Gymgrossisten and Bodystore, and is the biggest online health and sport nutrition company in the Nordic region. Through the Gymgrossisten and Bodystore eCommerce portals, HSNG offers dietary supplements, health and well-being products, activewear, equipment and accessories to a broad customer base in the Nordic region. Its sales portfolio includes proprietary brands and products distributed on behalf of third parties. The websites

Kielo makes its second acquisition in Finland

Helsinki, 21 November 2017The real estate company Kielo, managed by Brunswick Real Estate, has acquired nine office properties in the Finnish city of Jyväskylä.The recently established real estate company Kielo has made its second Finnish investment, acquiring an office portfolio from the property company Technopolis, listed on the Helsinki Stock Exchange. The properties are located in central Jyväskylä and comprise approximately 49,000 square meters of modern office premises. The acquisition also includes the current Technopolis management organisation in Jyväskylä, which will become

Multiconsult ASA – Repurchase of own shares

On 20 November 2017, Multiconsult ASA ("Multiconsult") purchased 500 of its own shares at an average price of NOK 75.99 per share. The shares were purchased in accordance with the Company's share repurchase programme as announced on 22 September 2017. The shares were acquired on Oslo Børs.Following this transaction Multiconsult holds 431 226 of its own shares.  For further information, please contact: Investor relations:      Mirza Koristovic, Head of Investor Relations      Phone: +47 93 87 05 25      E-mail: ir@multiconsult.no Media:      Gaute Christensen, VP

Höegh LNG : Mandatory Notification of Trade

Hamilton, Bermuda, 21 November 2017 - Höegh LNG Holdings Ltd. ("Höegh LNG" or the "Company") advises that Leif Höegh & Co. Ltd. ("LHC"), a primary insider of Höegh LNG, purchased 250,000 common shares in the Company on 20 November 2017 for a price of NOK 61.75 per share. Following the above transaction, Leif Höegh & Co. Ltd., which is indirectly controlled by Leif O. Høegh and by family trusts under which Morten W. Høegh is the primary beneficiary, holds a total of 32,229,953 shares, representing 41.7% of the shares in the Company and 311,591 common units in Höegh LNG Partners LP ("HMLP")

There are no items matching the current filter
There are no more items matching the current filter
Back to top